Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s share price dropped 0.4% during trading on Monday . The stock traded as low as $20.40 and last traded at $20.40. Approximately 750 shares were traded during trading, an increase of 321% from the average daily volume of 178 shares. The stock had previously closed at $20.48.
Hikma Pharmaceuticals Stock Performance
The company has a fifty day simple moving average of $22.16 and a two-hundred day simple moving average of $24.43. The company has a current ratio of 1.24, a quick ratio of 0.72 and a debt-to-equity ratio of 0.33.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- ServiceNow’s $7 Billion Gamble: Panic or Opportunity?
- What is the FTSE 100 index?
- Dell and HP Are Raising Prices—And Investors Should Take Note
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
